Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Evogene (EVGN) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Evogene (EVGN) over the last 13 years, with Q3 2025 value amounting to $12000.0.

  • Evogene's Non Operating Income rose 10146.16% to $12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 66627.78%. This contributed to the annual value of $4.0 million for FY2024, which is 67447.22% up from last year.
  • According to the latest figures from Q3 2025, Evogene's Non Operating Income is $12000.0, which was up 10146.16% from -$393000.0 recorded in Q2 2025.
  • Evogene's Non Operating Income's 5-year high stood at $4.6 million during Q4 2024, with a 5-year trough of -$1.7 million in Q2 2022.
  • For the 5-year period, Evogene's Non Operating Income averaged around $188684.2, with its median value being -$11000.0 (2022).
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 182727.27% in 2023, then skyrocketed by 109608.7% in 2024.
  • Over the past 5 years, Evogene's Non Operating Income (Quarter) stood at $602000.0 in 2021, then plummeted by 124.75% to -$149000.0 in 2022, then crashed by 208.72% to -$460000.0 in 2023, then skyrocketed by 1096.09% to $4.6 million in 2024, then tumbled by 99.74% to $12000.0 in 2025.
  • Its Non Operating Income stands at $12000.0 for Q3 2025, versus -$393000.0 for Q2 2025 and $1.1 million for Q1 2025.